These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 27045350)

  • 21. Assessment of cholesterol-derived ionic copolymers as potential vectors for gene delivery.
    Sevimli S; Sagnella S; Kavallaris M; Bulmus V; Davis TP
    Biomacromolecules; 2013 Nov; 14(11):4135-49. PubMed ID: 24125032
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Toxicogenomics of non-viral drug delivery systems for RNAi: potential impact on siRNA-mediated gene silencing activity and specificity.
    Akhtar S; Benter I
    Adv Drug Deliv Rev; 2007 Mar; 59(2-3):164-82. PubMed ID: 17481774
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hyperbranched polymeric "star vectors" for effective DNA or siRNA delivery.
    Nakayama Y
    Acc Chem Res; 2012 Jul; 45(7):994-1004. PubMed ID: 22353143
    [TBL] [Abstract][Full Text] [Related]  

  • 24. siRNA delivery by a transferrin-associated lipid-based vector: a non-viral strategy to mediate gene silencing.
    Cardoso AL; Simões S; de Almeida LP; Pelisek J; Culmsee C; Wagner E; Pedroso de Lima MC
    J Gene Med; 2007 Mar; 9(3):170-83. PubMed ID: 17351968
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Journey of siRNA: Clinical Developments and Targeted Delivery.
    Nikam RR; Gore KR
    Nucleic Acid Ther; 2018 Aug; 28(4):209-224. PubMed ID: 29584585
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polymeric siRNA gene delivery - transfection efficiency versus cytotoxicity.
    Kargaard A; Sluijter JPG; Klumperman B
    J Control Release; 2019 Dec; 316():263-291. PubMed ID: 31689462
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exosomes: Natural Carriers for siRNA Delivery.
    Kumar L; Verma S; Vaidya B; Gupta V
    Curr Pharm Des; 2015; 21(31):4556-65. PubMed ID: 26486142
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Delivering siRNA with Dendrimers: In Vivo Applications.
    Leiro V; Santos SD; Pego AP
    Curr Gene Ther; 2017; 17(2):105-119. PubMed ID: 28494741
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chitosan-based formulations for delivery of DNA and siRNA.
    Mao S; Sun W; Kissel T
    Adv Drug Deliv Rev; 2010 Jan; 62(1):12-27. PubMed ID: 19796660
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rapid delivery of small interfering RNA by biosurfactant MEL-A-containing liposomes.
    Inoh Y; Furuno T; Hirashima N; Kitamoto D; Nakanishi M
    Biochem Biophys Res Commun; 2011 Oct; 414(3):635-40. PubMed ID: 22001930
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liposomes and Lipid Envelope-Type Systems for Systemic siRNA Delivery.
    Vhora I; Patil S; Amrutiya J; Misra A
    Curr Pharm Des; 2015; 21(31):4541-55. PubMed ID: 26486141
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic targeting in the silent era: advances in non-viral siRNA delivery.
    Guo J; Fisher KA; Darcy R; Cryan JF; O'Driscoll C
    Mol Biosyst; 2010 Jul; 6(7):1143-61. PubMed ID: 20431817
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nonviral pulmonary delivery of siRNA.
    Merkel OM; Kissel T
    Acc Chem Res; 2012 Jul; 45(7):961-70. PubMed ID: 21905687
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The potential and advances in RNAi therapy: chemical and structural modifications of siRNA molecules and use of biocompatible nanocarriers.
    Joo MK; Yhee JY; Kim SH; Kim K
    J Control Release; 2014 Nov; 193():113-21. PubMed ID: 24862319
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Surface Engineered Dendrimers in siRNA Delivery and Gene Silencing.
    Tambe V; Thakkar S; Raval N; Sharma D; Kalia K; Tekade RK
    Curr Pharm Des; 2017; 23(20):2952-2975. PubMed ID: 28292248
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Advances in targeted delivery of small interfering RNA using simple bioconjugates.
    Nielsen C; Kjems J; Sørensen KR; Engelholm LH; Behrendt N
    Expert Opin Drug Deliv; 2014 May; 11(5):791-822. PubMed ID: 24669756
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Going beyond the liver: progress and challenges of targeted delivery of siRNA therapeutics.
    Lorenzer C; Dirin M; Winkler AM; Baumann V; Winkler J
    J Control Release; 2015 Apr; 203():1-15. PubMed ID: 25660205
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A biomimetic nanovector-mediated targeted cholesterol-conjugated siRNA delivery for tumor gene therapy.
    Ding Y; Wang W; Feng M; Wang Y; Zhou J; Ding X; Zhou X; Liu C; Wang R; Zhang Q
    Biomaterials; 2012 Dec; 33(34):8893-905. PubMed ID: 22979990
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficient targeted pDNA/siRNA delivery with folate-low-molecular-weight polyethyleneimine-modified pullulan as non-viral carrier.
    Wang J; Dou B; Bao Y
    Mater Sci Eng C Mater Biol Appl; 2014 Jan; 34():98-109. PubMed ID: 24268238
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor-targeting multifunctional nanoparticles for siRNA delivery: recent advances in cancer therapy.
    Ku SH; Kim K; Choi K; Kim SH; Kwon IC
    Adv Healthc Mater; 2014 Aug; 3(8):1182-93. PubMed ID: 24577795
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.